S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NRXP NRX Pharmaceuticals Inc

2.19

0.05 (2.34%)

Last Updated: 09:21:19

Delayed by 15 minutes

Biotech Soars On Large Investment Announcement Into Its Subsidiary

A Delaware-based biotech company turned heads on Tuesday after it was announced that it has invested $27 million in its subsidiary Hope Therapeutics to fund clinic acquisitions...

To read the full story on AllPennyStocks.com, click here.

NRX Pharmaceuticals (NASDAQ:NRXP)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more NRX Pharmaceuticals Charts.

NRX Pharmaceuticals (NASDAQ:NRXP)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more NRX Pharmaceuticals Charts.

NRX Pharmaceuticals Inc News

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025
Thursday 6 February 2025 (4 weeks ago) • PR Newswire (US)

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
Monday 3 February 2025 (1 month ago) • PR Newswire (US)

Biotech Soars On Large Investment Announcement Into Its Subsidiary
Tuesday 28 January 2025 (1 month ago) • AllPennyStocks.com

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
Tuesday 28 January 2025 (1 month ago) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Advances Relationship with Anson Funds with $8.9 Million Financing, Including Above the Market Equity and Senior Secured Debt
Tuesday 28 January 2025 (1 month ago) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement
Tuesday 21 January 2025 (1 month ago) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces the Appointment of Michael Taylor to its Board of Directors and Appointment of Anita Nunes as Board Observer; Ms. Nunes to be Appointed Director of HOPE Therapeutics, Inc.
Wednesday 15 January 2025 (2 months ago) • PR Newswire (US)

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel
Tuesday 14 January 2025 (2 months ago) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market
Monday 13 January 2025 (2 months ago) • PR Newswire (US)

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Conduct Investor Workshop at the Mar-A-Lago Club
Friday 10 January 2025 (2 months ago) • PR Newswire (US)

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th
Tuesday 7 January 2025 (2 months ago) • PR Newswire (US)

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
Monday 6 January 2025 (2 months ago) • PR Newswire (US)

More NRX Pharmaceuticals Inc News Articles

WisdomTree Commodity Sec...

Vanguard S&p 500 Ucits Etf

BNP Paribas Issuance

Vontobel Financial Produ...

Vontobel Financial Produ...

Societe Generale Effekten

Fineco Glob Clean Energy...

SG Issuer Sg Issuer Mc M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions